Cloetta (CLA) Q1 2025 earnings summary

Executive summary

• Achieved strong profitability improvement in Q1 2025, with adjusted operating profit margin rising to 11.0% from 9.2% year-over-year, despite a 2.6% decline in net sales to SEK 2,039m, impacted by Easter phasing, Nutisal divestment, and currency effects.

• Profit for the period more than doubled to SEK 253m (SEK 0.89 per share), supported by margin-enhancing initiatives and a one-time gain from the cancelled Greenfield project.

• Organizational restructuring underway, targeting up to 100 fewer positions and SEK 60–70 million in annual savings, with a one-time cost of SEK 60–70 million mostly recognized in Q2 2025.

• Strategic priorities include focus on 10 super brands, growth beyond core markets, increased marketing and innovation, and a new CEO appointed in June 2024.

• Market-leading positions in core markets with iconic brands and a diversified customer base, ensuring resilience and broad market reach.

Financial highlights

• Q1 2025 net sales of SEK 2,039m, down 2.6% year-over-year; organic growth -1.1% due to Easter phasing and portfolio optimization.

• Adjusted operating profit margin reached 11.0%, up 1.8 percentage points from last year.

• Reported operating profit margin exceeded 17% due to a one-time non-cash gain from discontinuing the Greenfield project.

• Free cash flow reached SEK 199 million, nearly double the prior year.

• Net debt/EBITDA at an all-time low of 1.1x, with net debt at SEK 1,327m.

Outlook and guidance

• Expects clear profitable sales growth in H1 2025 and aims for second-half growth near the new long-term target of 3–4%.

• Annual savings of SEK 60–70 million from organizational changes expected to have full effect in Q1 2026.

• Long-term organic growth target raised to 3–4%; adjusted EBIT target remains at 14%, with a commitment to reach at least 12% by 2027.

• Net debt target lowered to below 1.5, with flexibility for acquisitions.

• Pick & mix segment EBIT target updated to 7–9% (from 5–7%).